The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation

Nephrology Dialysis Transplantation

Volumn 23, Issue 4, 2008, Pages 1436-1441

  Porrini, Esteban ^a   Delgado, Patricia ^a   Alvarez, Alejandra ^a   Cobo, Marian ^a   Pérez, Lourdes ^a   González Posada, José M ^a   Hortal, Luis ^b   Gallego, Roberto ^b   García, José J ^c   Checa, Maria ^d   Morales, Adelaida ^e   Salido, Eduardo ^a,f,g   Hernández, Domingo ^a   Torres, Armando ^a,f,g  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^c HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^d HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

^e HOSPITAL GENERAL DE LANZAROTE   (Spain)

^f Instituto Reina Sofia de Investigacion Nefrologica   (Spain)

^g UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Insulin resistance; NODAT; Tacrolimus

Indexed keywords

BASILIXIMAB; CALCINEURIN INHIBITOR; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; TACROLIMUS; THIMOGLOBULIN; TRIACYLGLYCEROL; BIOLOGICAL MARKER; CALCINEURIN; CYCLOSPORIN; GLUCOCORTICOID;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SINGLE DRUG DOSE; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; COMPARATIVE STUDY; DRUG ANTAGONISM; GRAFT REJECTION; INCIDENCE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDY; SPAIN; TIME;

BIOLOGICAL MARKERS; CALCINEURIN; CYCLOSPORINE; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; GRAFT REJECTION; HUMANS; HYPERTRIGLYCERIDEMIA; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INSULIN RESISTANCE; KIDNEY TRANSPLANTATION; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN; TACROLIMUS; TIME FACTORS; TRIGLYCERIDES;

EID: 42949174238     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm762     Document Type: Article

References (22)

1. Kasiske B, Snyder D, Gilbertone D et al. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178-185
2. Hjelmesaeth J, Hartman A, Leivestad T et al. The impact of early-diagnosed new-onset post-transplantation diabetes on survival and major cardiac events. Kidney Int 2006; 69: 588-595
3. Heisel O, Heisel R, Balshw R et al. New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. Am J Transplant 2004; 4: 583-595
4. Weir M, Fink Jeffrey. Risk for posttransplantation diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis 1999; 1: 1-13
5. Markell Mariana. New-Onset diabetes mellitus in transplant patients: pathogenesis, complications, and management. Am J Kidney Dis 2004; 6: 953-965
6. Oterdoom L, de Vries A, Gansevort R et al. Determinants of insulin resistance in renal transplant recipients. Transplantation 2007; 81: 29-35
7. Oetjen E, Baun D, Beimesche S et al. Inhibition of human insulin gene transcription by the immnosuppressive drugs cyclosporin A and tacrolimus in primary, mature islets of transgenic mice. Mol Pharmacol 2003; 63: 1289-1295
8. Stumvoll M, Goldstein B, van Heften T. Type 2 diabetes: principles of pathogenesis and therapy. The Lancet 2005; 365: 1333-1346
9. McLaughlin T, Reaven G, Abbasi F et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol 2005; 96: 399-404
10. Boots J, Christiaans M, van Hooff. Effect of immunosuppressive agents on long-term survival of renal transplant recipients. Drugs 2004; 64: 2047-2073
11. Vincenti F, Friman S, Scheuermann E et al. Results of an international, randomized, trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 2007; 7: 1506-1514
12. Porrini E, Delgado P, Alvarez A et al. Impact of metabolic syndrome on grafo function and survival alter cadaveric renal transplantation. Am J Kidney Dis 2006; 48: 134-142
13. Anonymous. Diagnosis and classification of diabetes mellitus. Diabetes Care 2005; 28: s37-s42
14. Mariat C, Alamartine E, Barthelemy JC et al. Assesing renal graft function in clinical trials: can tests predicting glomerular filtration rate substitute for a reference method? Kidney Int. 2003; 65: 289-297
15. Anonymous. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high cholesterol in adults (adult treatment panel III) final report. Circulation 2002; 106: 3143-3421
16. McLaughlin T, Abbasi F, Cheal K et al. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 2003; 139: 802-809
17. Reaven G. Importance of identifying the overweight patients who will benefit the most by losing weight. Ann Intern Med 2003; 138: 420-423
18. Bos G, Dekker J, Nijpels G et al. A combination of high concentrations of serum triglyceride and non-high-density-lipoprotein- cholesterol is a risk factor for cardiovascular disease in subjects with abnormal glucose metabolism - the Hoorn study. Diabetologia 2003; 46: 910-916
19. Chan MK, Varghese Z, Persaud JW et al. Hyperlipidemia in patients on maintenance hemo- and peritoneal dialysis: the relative pathogenetic roles of triglyceride production and triglyceride removal. Clin Nephrol 1982; 17: 183-190
20. Fukudo M, Ikudo I, Masuda S et al. Distinct inhibitory effects of tacrolimus and cyclosporine A on calcineurin phophatase activity. J Pharmacol Exp Therapy 2005; 312: 816-825
21. Maes B, Kuypers, Messiaen T et al. Posttransplantaion diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors. Transplantation 2001; 72: 1655-1661
22. van Hooff J, Christiaans M, van Duijnhoven E. Tacrolimus and posttransplant diabetes mellitus in renal transplantation. Transplantation 2005; 79: 1465-1469